← The Wire
COLLNasdaq
COLLEGIUM PHARMACEUTICAL, INC
Pharmaceutical Preparations · VA · CIK 1267565
Develops, licenses, acquires, and commercializes differentiated pharmaceutical products for ADHD and moderate to severe pain
red 8-K · 90d
$1.12B
Market cap
$35.98
Last close
-1.7%
1D
+7.6%
5D
511K
Volume
Price · last 39 sessions+4.0%
May 4L $30.48 · H $39.33Jun 29
224
Total filings
May 15, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 15, 20268-KExecutive Change · Acquisition / DispositionMay 12, 202610-Q10-QMay 7, 20268-KResults of Operations · Reg FD DisclosureMay 7, 2026DEF 14ADEF 14AApr 7, 20268-KExecutive ChangeApr 7, 20268-KMaterial Agreement · Reg FD DisclosureMar 19, 202610-K10-KFeb 26, 20268-KResults of Operations · Reg FD DisclosureFeb 26, 20268-KReg FD DisclosureJan 8, 20268-KMaterial Agreement · Agreement TerminatedDec 30, 202510-Q10-QNov 6, 20258-KResults of Operations · Reg FD DisclosureNov 6, 202510-Q10-QAug 7, 20258-KResults of Operations · Reg FD DisclosureAug 7, 20258-KCompany UpdateJul 7, 20258-KExecutive Change · Shareholder VoteMay 19, 20258-KCompany UpdateMay 12, 202510-Q10-QMay 8, 20258-KResults of Operations · Reg FD DisclosureMay 8, 2025DEFA14ADEFA14AMar 28, 2025DEF 14ADEF 14AMar 28, 20258-KExecutive Change · Company UpdateMar 17, 202510-K10-KFeb 27, 20258-KExecutive Change · Results of OperationsFeb 27, 20258-KExecutive ChangeFeb 5, 20258-KReg FD DisclosureJan 8, 20258-K/ACompany UpdateNov 14, 2024SC 13GPRINCIPAL GLOBAL INVESTORSNov 13, 202410-Q10-QNov 7, 20248-KExecutive Change · Results of OperationsNov 7, 20248-KAcquisition / Disposition · New Debt / ObligationSep 4, 202410-Q10-QAug 8, 20248-KResults of Operations · Reg FD DisclosureAug 8, 20248-KExecutive Change · Material AgreementJul 29, 20248-KCompany UpdateJun 13, 20248-KExecutive ChangeMay 24, 20248-KShareholder VoteMay 20, 20248-KCompany UpdateMay 13, 2024DEFA14ADEFA14AMay 10, 20248-KExecutive ChangeMay 10, 202410-Q10-QMay 9, 20248-KResults of Operations · Reg FD DisclosureMay 9, 20248-KMaterial AgreementApr 29, 20248-KCompany UpdateApr 11, 2024DEFA14ADEFA14AApr 5, 2024DEF 14ADEF 14AApr 5, 202410-K10-KFeb 22, 20248-KResults of Operations · Reg FD DisclosureFeb 22, 20248-KReg FD Disclosure · Company UpdateJan 3, 20248-KCompany UpdateNov 9, 202310-Q10-QNov 7, 20238-KResults of Operations · Reg FD DisclosureNov 7, 20238-KCompany UpdateAug 24, 20238-KCompany UpdateAug 7, 20238-KResults of Operations · Reg FD DisclosureAug 3, 202310-Q10-QAug 3, 20238-KShareholder VoteMay 19, 202310-Q10-QMay 4, 20238-KResults of Operations · Reg FD DisclosureMay 4, 2023DEF 14ADEF 14AApr 11, 202310-K10-KFeb 23, 20238-KResults of Operations · Reg FD DisclosureFeb 23, 20238-KMaterial Agreement · New Debt / ObligationFeb 13, 20238-KResults of Operations · Reg FD DisclosureFeb 6, 20238-KReg FD Disclosure · Company UpdateJan 4, 20238-KReg FD Disclosure · Company UpdateDec 22, 202210-Q10-QNov 3, 20228-KResults of Operations · Reg FD DisclosureNov 3, 202210-Q10-QAug 4, 20228-KResults of Operations · Reg FD DisclosureAug 4, 20228-KShareholder VoteMay 23, 20228-K/ACompany UpdateMay 13, 202210-Q10-QMay 10, 20228-KResults of Operations · Reg FD DisclosureMay 10, 20228-KReg FD DisclosureApr 13, 2022DEFA14ADEFA14AApr 6, 2022DEF 14ADEF 14AApr 6, 20228-KExecutive ChangeApr 6, 20228-KReg FD DisclosureApr 5, 2022
Insider Activity
In the 90 days to Mar 18, 2026: 2 sold $2.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Dieter DavidEVP & General Counsel | Sell | 13,976 | $34.92 | $488K |
| Mar 9, 2026 | Dieter DavidEVP & General Counsel | Sell | 6,224 | $36.65 | $228K |
| Mar 3, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Sell | 46,417 | $40.36 | $1.9M |
| Mar 3, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Sell | 3,559 | $40.99 | $146K |
| Dec 8, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Sell | 11,125 | $47.89 | $533K |
| Dec 8, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Sell | 6,475 | $48.66 | $315K |
| Dec 5, 2025 | Balice-Gordon Rita J.Director | Sell | 3,650 | $47.03 | $172K |
| Nov 12, 2025 | Fallon John A.Director | Sell | 34,853 | $47.21 | $1.6M |
| Nov 6, 2025 | Tupper ColleenEVP & Chief Financial Officer | Sell | 25,142 | $40.38 | $1.0M |
| Nov 6, 2025 | Tupper ColleenEVP & Chief Financial Officer | Sell | 4,858 | $41.28 | $201K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance